摘要
在全世界,肝细胞癌(HCC)是第五位最普通的癌,在癌死亡率中是第三位最重要的原因,5年生存率仅仅7%。HCC是在慢性肝病(如肝硬化)的基础上发展的,它是一种预后很差的疾病。因此,密切追踪肝硬化病人是重要的,以便在早期阶段检出HCC,进行最佳治疗。当前用以诊断和过筛HCC的常规方法包括物理检查,超声影像学检查及血清甲胎蛋白(AFP)浓度测定。最近20年来,AFP的有关参数(如AFP mRNA和AFP的糖化型)得到广泛地研究,用作可能的新标志物诊断和监测HCC。本文简要介绍AFP及它的有关参数在诊断和监测HCC时的现代认识。
出处
《中国医师杂志》
CAS
2009年第10期1437-1439,共3页
Journal of Chinese Physician
参考文献17
-
1Bosch FX,Ribes J,Clerics R,et al.Epidemiology of hepatocellular carcinoma.Clin Liver Dis,2005,9:191-211.
-
2Verhoef C,Visser O,de Man RA,et al.Hepatocellular carcinoma in the Netherlands incidence,treatment and survival patterns.Eur JCancer,2004,40:1530-1538.
-
3Avila MA,Berasain C,Sangro B,et al.New therapics for hepatocellular carcinoma.Oneogene,2006,25:3866-3884.
-
4Trcvisani F,Otntino PE,Momalli-Labate AM,et al.Serum alpha-fetoprotin for diagnosis of hepatocellular carcinoma in patients with chronic liver disease:influence of HBsAg and anti-HCV status.J Hepatol,2001,34:570-575.
-
5Gambarin-Celwan M,Wolf DC,Shapiro R,et al.Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.Am J Gastroenterol,2000,95:1535-1538.
-
6Cedrone A,Covino M,Caturelli E,et al.Utility of alpha-fetoprotein (AFP)in the screening of patients with virus-related chronic liver disease:does different viral etiology influence AFP levels in HCC?A study in 350 western patients.Hepatogastroenterology,2000,47:1654-1658.
-
7Li D,Mallory T,Satomura S.AFP-L3:a new generation of tumor marker for hepatocellular carcinoma.Clin Chim Acta,2001,313:15-19.
-
8Yarngata Y,shirmizu K,Nakamura K,et al.Simultaneous determination of percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein and alpha-fetoprotein concentration using the LiBASys clinicalauto-analyst.Clin chim Acta,2003,327:59-67.
-
9Taketa K,Okada S,Win N,et al.Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital,Myanmar.Acta Med Okayama.2002,56:317-320.
-
10Ichikawa E,Kurivanma S,Yuii J,et al.Further resolution of alphafetoprotein glycoforms by two-dimensional isoelectric focusing and lectin affinity electrophoresis.Electrophoresis,2006,27:3480-3487.
同被引文献12
-
1Inagaki Y, Tang W, Makuuchi M, et al. Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-gam- ma-carboxypmthrombin[J]. Liver Int, 2011, 31 (1): 22-35.
-
2Lok AS, Sterling RK, Everhart JE, et al. Des-gamma-carboxy prothmmbin and alpha-fetoprotein as biomarkers for the early de- tection of hepatocellular carcinoma[J]. Gastroenterology, 2010, 138(2) :493-502.
-
3Erfle JM, Heider D, Wichert M, et al. A combination of alpha-fe- toprotein and des-gamma-carboxy pmthrombin is superior in detec- tion of hepatocellular carcinoma [ J]. Digestion, 2013, 87 (2) : 121-131.
-
4Jang ES, Je0ng SH, Kim JW, et al. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Os- teopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma[J]. PLoS One, 2016, 11(3):e0151069.
-
5Abd Gawad IA, Mossallam GI, Radwan NH, et al. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcino- embryonic antigen in diagnosing hepatocellular carcinoma amou$ Egyptianpatients [J]. J Egypt Nail Canc Inst, 2014,26(2) :79- 85.
-
6Park H, Park JY. Clinical significance of AFP and PIVKA-II re- sponses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma [ J ]. Biomed Res Int,2013,2013:310427.
-
7Yamamoto K, lmamura H, Matsuyama Y, et al. AFP, AFP-L3, DCPand GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of elinieopathologieal variables of HCC [ J]. J Gastroenterol, 2010, 45 (12) : 1272-1282.
-
8贾继东,李兰娟.慢性乙型肝炎防治指南(2010年版)[J].中华内科杂志,2011,50(2):168-179. 被引量:242
-
9原发性肝癌诊疗规范(2011年版)[J].临床肿瘤学杂志,2011,16(10):929-946. 被引量:988
-
10王建美,杨宏远.MRI检查联合AFP及GP73检测对早期肝癌的诊断价值[J].中国医师杂志,2013,15(6):788-790. 被引量:4
二级引证文献4
-
1罗丽丹,张斌,李江,胡小宣.PIVKA-Ⅱ和AFP对原发性肝癌诊断价值的评估[J].国际检验医学杂志,2018,39(14):1721-1724. 被引量:9
-
2徐建,许亮亮,喻海忠.TASwako i30全自动免疫仪检测仪性能评价[J].国际感染病学(电子版),2019,8(3):7-9.
-
3杨启,吕新远,万春.PIVKA-Ⅱ、AFP在原发性肝癌中的诊断价值研究[J].中国现代普通外科进展,2020,23(12):982-983. 被引量:4
-
4贾发俊.恩替卡韦与阿德福韦酯治疗慢性乙型病毒性肝炎的抗病毒效果及毒副作用比较[J].中国执业药师,2018,15(12):94-96. 被引量:5
-
1Steven D. Wexner Badma Bashankaev.低位直肠癌保肛手术的现状与争议[J].中华外科杂志,2009,47(13):971-974. 被引量:10
-
2陈彬然.浅析超声影像学检查在乳腺癌中的应用价值[J].世界最新医学信息文摘,2015,15(31):156-157. 被引量:3
-
3周洁.超声诊断黏液性囊腺癌一例[J].现代医学,2014,42(3):328-329.
-
4徐洪洁.癌症疼痛的现代认识和心理护理[J].新中医,2012,44(4):143-144. 被引量:4
-
5田继伟,裴晴,崔亚琼.宫颈癌磁共振成像分期及淋巴结转移的价值[J].中国药物与临床,2014,14(3):358-360. 被引量:4
-
6岳林先.骨外骨肉瘤超声表现1例[J].中国超声医学杂志,2006,22(8):566-566.
-
7张国明,胡礼仪.肺癌的新型标志Cytokaratin19的研究现状[J].牡丹江医学院学报,2011,32(3):70-72. 被引量:3
-
8卫建平,王晨,王晶昌,姚建宏.端粒酶-HTR在癌及癌前病变中表达的意义探讨[J].山西医药杂志,1998,27(3):4-6. 被引量:2
-
9王晓亮,李绍刚,李赛飞,康旭,汪亚航,王军,王东海,金来伦.乳腺癌组织中Bmi-1蛋白表达与病理学特征的相关性研究[J].成都医学院学报,2013,8(2):165-167. 被引量:2
-
10张颖,向阳.妊娠滋养细胞疾病的肿瘤标志物及其研究进展[J].中国实用妇科与产科杂志,2003,19(3):187-191. 被引量:2